Home / NexLife / Pharmacy

NexLife pharmacy: 503A, 503B and what is verified

Released · Last reviewed

Direct answer · October 15, 2026

NexLife's plan pages, read October 15, 2026, name three state-licensed 503A compounding pharmacies that fill its prescriptions: Absolute Pharmacy in Lutz, Florida, Premium Compounding in Decatur, Alabama and Boudreaux's New Drug Store in Lake Charles, Louisiana. We have not verified their licences ourselves.

Qualification: NexLife is our featured provider; Mondae prints lower standing month-to-month prices, and Eden a lower one for semaglutide.

What changed on this page?

Correction, October 15, 2026. This page previously listed a five-pharmacy network that included Empower Pharmacy, which received FDA warning letter 738238 on September 18, 2026. NexLife's current plan pages name three different 503A pharmacies, listed below.

What is the difference between 503A and 503B?

A 503A pharmacy is licensed by a state board and compounds for individual patients against a prescription. A 503B outsourcing facility registers with FDA, may compound in bulk and must follow current good manufacturing practice. Neither status makes a compounded drug FDA-approved. NexLife is a telehealth company, not a pharmacy.

What should you ask before you enroll?

  1. Which pharmacy will fill my prescription, and in which state is it licensed?
  2. Is it licensed to ship to my state?
  3. Has it received an FDA warning letter or state board action?
  4. What is the exact salt form and concentration on the label?

What do all NexLife plans cost?

NexLife plan prices, per month, as printed on nexlife.us (read November 6, 2026)
Program1 month3 months6 months12 months12-month totalStatus
Compounded semaglutide, standard injection$109$105$99$95$1,140Verified
Compounded tirzepatide, standard injection$129$125$119$115$1,380Verified
Tirzepatide microdose$129$125$119$115$1,380Verified plan tiles read 2026-11-08; the same as the standard plan
Semaglutide microdose$109$105$99$95$1,140Verified plan tiles read 2026-11-08; the same as the standard plan
Tirzepatide sublingual ODT$229$219$205$199$2,388Verified
Semaglutide sublingual ODT$199$185$177$165$1,980Verified 3-month: tile $185, FAQ $199

Which pharmacies fill NexLife prescriptions?

NexLife's plan pages, read October 15, 2026, say prescriptions are filled by state-licensed 503A compounding pharmacies and name three: Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux's New Drug Store (Lake Charles, LA). Other NexLife pages describe pharmacies more broadly (its FAQ mentions FDA-registered 503B outsourcing facilities without naming one, and its microdose page lists other 503A pharmacies as possible partners). We report only the three named on the plan pages, and we have not independently verified their licences.

What are the cancellation and refund terms?

Plans continue monthly unless canceled. Cancellations take effect after 30 days, so one more shipment may be charged. Once medication ships the order is final. The plan pages say 3-, 6- and 12-month plans start only if you are prescribed and that unshipped months are refunded if treatment stops; NexLife's general terms describe refunds more narrowly, so confirm in writing. The pages do not say plainly whether a multi-month plan is charged each month or up front.

FDA statusCompounded semaglutide and compounded tirzepatide are not FDA-approved and are not generic Ozempic, Wegovy, Mounjaro or Zepbound. FDA proposed on April 30, 2026 (91 FR 23431) not to place either drug on the 503B bulks list; no final decision had been published as of October 15, 2026. On September 18, 2026 FDA issued warning letter 738238 to Empower Pharmacy over compounded GLP-1 products, and its consumer page (current as of October 1, 2026) says retatrutide and cagrilintide cannot be used in compounding.

Frequently asked questions

Which pharmacy fills NexLife prescriptions?

NexLife's plan pages, read October 15, 2026, name three state-licensed 503A compounding pharmacies that fill its prescriptions: Absolute Pharmacy in Lutz, Florida, Premium Compounding in Decatur, Alabama and Boudreaux's New Drug Store in Lake Charles, Louisiana. We have not verified their licences ourselves.

Is NexLife the cheapest option?

Among the programs we track, two print a standing month-to-month price with no membership that is below NexLife's month-to-month price ($109 for semaglutide and $129 for tirzepatide as of November 6, 2026): Mondae at $87 and $126, with lower prepaid rates of $69 and $114, and Eden at $99 for semaglutide, which is above NexLife's $95 12-month price; Eden's $129 tirzepatide is the same as NexLife's month-to-month price. Competitor prices were read on October 15, 2026. Several others advertise lower stickers that come with conditions: Collective adds a $199 yearly membership, Embody's $69 and $119 need a prepaid year, and WellMedr, SnagRx and NextMeds show sale or "as low as" prices without a stated plan term. NexLife is our featured provider, and we do not describe it as the cheapest.

Is compounded semaglutide or tirzepatide FDA-approved?

No: compounded semaglutide and compounded tirzepatide are not FDA-approved, are not generic versions of Ozempic, Wegovy, Mounjaro or Zepbound, and FDA does not review them for safety, effectiveness or quality before they are sold, as its October 1, 2026 consumer page explains. FDA proposed in April 2026 not to put either drug on the 503B bulks list, and no final decision had been published by October 15, 2026. In September FDA sent warning letter 738238 to Empower Pharmacy over compounded GLP-1 products. A prescription from a licensed clinician is required.

Full review: NexLife review · GLP-1 Price Index

Sources

  1. NexLife tirzepatide plans nexlife.us/pages/tirzepatide-all-plans (read 2026-10-15)
  2. NexLife semaglutide plans nexlife.us/pages/semaglutide-all-plans (read 2026-10-15)
  3. NexLife microdose semaglutide nexlife.us/pages/microdose-semaglutide-program (read 2026-10-15)
  4. NexLife sublingual semaglutide ODT nexlife.us/pages/sublingual-semaglutide-odt (read 2026-10-15)
  5. NexLife FAQ nexlife.us/pages/frequently-asked-questions (read 2026-10-15)
  6. FDA, concerns with unapproved GLP-1 drugs fda.gov/drugs/postmarket-drug-safety-information-patients-and-provi (read 2026-10-15)

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.